checkAd
    Startseite > Aktien > Veracyte > Nachrichten
    Veracyte Aktie
    19,550
     
    EUR
    +0,51 %
    +0,100 EUR
    Letzter Kurs 22:15:23 Lang & Schwarz
    19,300
     
    EUR
    393 STK
    Geldkurs 22:15:23
    19,800
     
    EUR
    393 STK
    Briefkurs 22:15:23
    ISIN: US92337F1075 · WKN: A1W7EA · USA

    Neueste Nachrichten

    Veracyte Announces First Quarter 2024 Financial Results
    22:05 Uhr · Business Wire (engl.) · Veracyte
    14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease Understanding
    06.05.24 · Business Wire (engl.) · Veracyte
    Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024
    22.04.24 · Business Wire (engl.) · Veracyte
    New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance
    22.04.24 · Business Wire (engl.) · Veracyte
    Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024
    16.04.24 · Business Wire (engl.) · Veracyte
    Veracyte’s Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines
    27.02.24 · Business Wire (engl.) · Veracyte
    Veracyte Announces Fourth Quarter and Full-Year 2023 Financial Results
    22.02.24 · Business Wire (engl.) · Veracyte
    Veracyte to Participate in the Raymond James 45th Annual Institutional Investors Conference
    21.02.24 · Business Wire (engl.) · Veracyte
    Veracyte to Release Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024
    08.02.24 · Business Wire (engl.) · Veracyte
    Veracyte Completes Acquisition of C2i Genomics
    06.02.24 · Business Wire (engl.) · Veracyte
    Veracyte Announces Preliminary Full-Year 2023 Results, Acquisition of C2i Genomics to Add Minimal Residual Disease Capabilities to Its Novel Diagnostics Platform
    08.01.24 · Business Wire (engl.) · Veracyte
    Veracyte to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
    12.12.23 · Business Wire (engl.) · Veracyte